Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The measurement of some residual C-peptide would further strengthen the case for using these medications
2022 Apr 1;28(2):500-535
Clinical trials are raising the bar Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly sema + once-weekly insulin Even more exciting
If you cant get them covered by insurance, theyre also incredibly expensive
US$ 24.06
US$ 22.38
US$ 26.25
US$ 22.74
